Literature DB >> 22036947

Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis.

Timo Schwandt1, Beatrix Schumak, Gerrit H Gielen, Frank Jüngerkes, Patricia Schmidbauer, Katrin Klocke, Andrea Staratschek-Jox, Niko van Rooijen, Georg Kraal, Isis Ludwig-Portugall, Lars Franken, Sven Wehner, Jörg C Kalff, Olaf Weber, Carsten Kirschning, Christoph Coch, Ulrich Kalinke, Jörg Wenzel, Christian Kurts, Rainer Zawatzky, Bernhard Holzmann, Laura Layland, Joachim L Schultze, Sven Burgdorf, Joke M M den Haan, Percy A Knolle, Andreas Limmer.   

Abstract

Early during Gram-negative sepsis, excessive release of pro-inflammatory cytokines can cause septic shock that is often followed by a state of immune paralysis characterized by the failure to mount adaptive immunity towards secondary microbial infections. Especially, the early mechanisms responsible for such immune hypo-responsiveness are unclear. Here, we show that TLR4 is the key immune sensing receptor to initiate paralysis of T-cell immunity after bacterial sepsis. Downstream of TLR4, signalling through TRIF but not MyD88 impaired the development of specific T-cell immunity against secondary infections. We identified type I interferon (IFN) released from splenic macrophages as the critical factor causing T-cell immune paralysis. Early during sepsis, type I IFN acted selectively on dendritic cells (DCs) by impairing antigen presentation and secretion of pro-inflammatory cytokines. Our results reveal a novel immune regulatory role for type I IFN in the initiation of septic immune paralysis, which is distinct from its well-known immune stimulatory effects. Moreover, we identify potential molecular targets for therapeutic intervention to overcome impairment of T-cell immunity after sepsis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22036947      PMCID: PMC3252580          DOI: 10.1038/emboj.2011.380

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  62 in total

1.  Bone marrow as a priming site for T-cell responses to blood-borne antigen.

Authors:  Markus Feuerer; Philipp Beckhove; Natalio Garbi; Yolanda Mahnke; Andreas Limmer; Mirja Hommel; Günter J Hämmerling; Bruno Kyewski; Alf Hamann; Viktor Umansky; Volker Schirrmacher
Journal:  Nat Med       Date:  2003-08-10       Impact factor: 53.440

2.  Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.

Authors:  Agnes Le Bon; Nathalie Etchart; Cornelia Rossmann; Miranda Ashton; Sam Hou; Dirk Gewert; Persephone Borrow; David F Tough
Journal:  Nat Immunol       Date:  2003-09-21       Impact factor: 25.606

Review 3.  Inferences, questions and possibilities in Toll-like receptor signalling.

Authors:  Bruce Beutler
Journal:  Nature       Date:  2004-07-08       Impact factor: 49.962

4.  Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock.

Authors:  Marina Karaghiosoff; Ralf Steinborn; Pavel Kovarik; Gernot Kriegshäuser; Manuela Baccarini; Birgit Donabauer; Ursula Reichart; Thomas Kolbe; Christian Bogdan; Tomas Leanderson; David Levy; Thomas Decker; Mathias Müller
Journal:  Nat Immunol       Date:  2003-04-07       Impact factor: 25.606

Review 5.  Type I interferon: friend or foe?

Authors:  Giorgio Trinchieri
Journal:  J Exp Med       Date:  2010-09-13       Impact factor: 14.307

6.  Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.

Authors:  Masahiro Yamamoto; Shintaro Sato; Hiroaki Hemmi; Katsuaki Hoshino; Tsuneyasu Kaisho; Hideki Sanjo; Osamu Takeuchi; Masanaka Sugiyama; Masaru Okabe; Kiyoshi Takeda; Shizuo Akira
Journal:  Science       Date:  2003-07-10       Impact factor: 47.728

7.  Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection.

Authors:  Kenya Honda; Shinya Sakaguchi; Chigusa Nakajima; Ai Watanabe; Hideyuki Yanai; Misako Matsumoto; Toshiaki Ohteki; Tsuneyasu Kaisho; Akinori Takaoka; Shizuo Akira; Tsukasa Seya; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

8.  Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.

Authors:  K Hoebe; X Du; P Georgel; E Janssen; K Tabeta; S O Kim; J Goode; P Lin; N Mann; S Mudd; K Crozat; S Sovath; J Han; B Beutler
Journal:  Nature       Date:  2003-07-20       Impact factor: 49.962

9.  Identification of a TLR4- and TRIF-dependent activation program of dendritic cells.

Authors:  Heike Weighardt; Gabriela Jusek; Jörg Mages; Roland Lang; Kasper Hoebe; Bruce Beutler; Bernhard Holzmann
Journal:  Eur J Immunol       Date:  2004-02       Impact factor: 5.532

Review 10.  The immunopathogenesis of sepsis.

Authors:  Jonathan Cohen
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

View more
  20 in total

Review 1.  The interaction between invariant Natural Killer T cells and the mucosal microbiota.

Authors:  Fatma Zehra Hapil; Gerhard Wingender
Journal:  Immunology       Date:  2018-07-11       Impact factor: 7.397

2.  Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections.

Authors:  Dana T Lounder; Qiong Bin; Cristina de Min; Michael B Jordan
Journal:  Blood Adv       Date:  2019-01-08

3.  Macrophage heterogeneity in lymphoid tissues.

Authors:  Joke M M den Haan; Luisa Martinez-Pomares
Journal:  Semin Immunopathol       Date:  2013-04-12       Impact factor: 9.623

4.  Type I IFN signaling in CD8- DCs impairs Th1-dependent malaria immunity.

Authors:  Ashraful Haque; Shannon E Best; Marcela Montes de Oca; Kylie R James; Anne Ammerdorffer; Chelsea L Edwards; Fabian de Labastida Rivera; Fiona H Amante; Patrick T Bunn; Meru Sheel; Ismail Sebina; Motoko Koyama; Antiopi Varelias; Paul J Hertzog; Ulrich Kalinke; Sin Yee Gun; Laurent Rénia; Christiane Ruedl; Kelli P A MacDonald; Geoffrey R Hill; Christian R Engwerda
Journal:  J Clin Invest       Date:  2014-05-01       Impact factor: 14.808

Review 5.  The significance and regulatory mechanisms of innate immune cells in the development of sepsis.

Authors:  Ying-Yi Luan; Ning Dong; Meng Xie; Xian-Zhong Xiao; Yong-Ming Yao
Journal:  J Interferon Cytokine Res       Date:  2013-09-05       Impact factor: 2.607

6.  Escherichia coli-induced immune paralysis is not exacerbated during chronic filarial infection.

Authors:  Benedikt C Buerfent; Fabian Gondorf; Dirk Wohlleber; Beatrix Schumak; Achim Hoerauf; Marc P Hübner
Journal:  Immunology       Date:  2015-05       Impact factor: 7.397

7.  Type I interferons promote severe disease in a mouse model of lethal ehrlichiosis.

Authors:  Yubin Zhang; Vinh Thai; Amanda McCabe; Maura Jones; Katherine C MacNamara
Journal:  Infect Immun       Date:  2014-02-03       Impact factor: 3.441

Review 8.  Why is Listeria monocytogenes such a potent inducer of CD8+ T-cells?

Authors:  Alfredo Chávez-Arroyo; Daniel A Portnoy
Journal:  Cell Microbiol       Date:  2020-04       Impact factor: 3.715

9.  Both very low- and very high in vitro cytokine responses were associated with infant death in low-birth-weight children from Guinea Bissau.

Authors:  Andreas Andersen; Kristoffer J Jensen; Christian Erikstrup; Henrik Ravn; Ane B Fisker; Ida M Lisse; Erliyani Sartono; Peter Aaby; Maria Yazdanbakhsh; Christine S Benn
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

10.  Host responses to sepsis vary in different low-lethality murine models.

Authors:  Lori F Gentile; Dina C Nacionales; M Cecilia Lopez; Erin Vanzant; Angela Cuenca; Benjamin E Szpila; Alex G Cuenca; Anna Joseph; Frederick A Moore; Christiaan Leeuwenburgh; Henry V Baker; Lyle L Moldawer; Philip A Efron
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.